Analysts Set Repligen Co. (NASDAQ:RGEN) Price Target at $185.20

6 hours ago · Brokerages Set Trustmark Co. (NASDAQ:TRMK) Price Target at $35.20; Analysts Set Repligen Co. (NASDAQ:RGEN) Price Target at $185.20; Brokerages Set Definity …

$185.20
OFF

Analysts Set Repligen Co. (NASDAQ:RGEN) Price Target At $185.20

2 weeks from now

6 hours ago · Brokerages Set Trustmark Co. (NASDAQ:TRMK) Price Target at $35.20; Analysts Set Repligen Co. (NASDAQ:RGEN) Price Target at $185.20; Brokerages Set Definity …

etfdailynews.com

$185.20
OFF

Repligen (RGEN) Stock Forecast And Price Target 2025 - MarketBeat

2 weeks from now

6 days ago · According to the 13 analysts' twelve-month price targets for Repligen, the average price target is $185.20. The highest price target for RGEN is $220.00, while the lowest price …

marketbeat.com

$185.20
OFF

Repligen Co. (NASDAQ:RGEN) Receives $185.20 Consensus Price …

2 weeks from now

Dec 21, 2024 · Repligen Co. (NASDAQ:RGEN – Get Free Report) has earned a consensus rating of “Moderate Buy” from the thirteen ratings firms that are covering the company, Marketbeat …

americanbankingnews.com

$185.20
OFF

Repligen Co. (NASDAQ:RGEN) Receives $185.20 Average Target …

2 weeks from now

Dec 21, 2024 · Repligen Co. (NASDAQ:RGEN – Get Free Report) has been given an average recommendation of “Moderate Buy” by the thirteen brokerages that are currently covering the …

tickerreport.com

$211
OFF

Repligen Corporation: Target Price Consensus And Analysts ...

2 weeks from now

Oct 9, 2024 · UBS Adjusts Repligen Price Target to $211 From $170, Maintains Buy Rating 15/12: MT Benchmark Downgrades Repligen to Hold From Buy 04/12: MT Deutsche Bank …

marketscreener.com

54%
OFF

Benchmark Initiates Coverage Of Repligen (RGEN) With Buy

2 weeks from now

Mar 29, 2023 · Analyst Price Forecast Suggests 23.54% Upside As of March 29, 2023, the average one-year price target for Repligen is $207.26. The forecasts range from a low of …

nasdaq.com

92%
OFF

Does Repligen Corp. (RGEN) Have A Bright Future? - Yahoo Finance

2 weeks from now

On November 14, 2023, Repligen Corporation (NASDAQ:RGEN) stock closed at $153.79 per share. One-month return of Repligen Corporation (NASDAQ:RGEN) was 7.92%, and its …

yahoo.com

$207.00
OFF

RBC Capital Keeps Their Buy Rating On Repligen (RGEN)

2 weeks from now

1 day ago · RBC Capital analyst Conor McNamara maintained a Buy rating on Repligen (RGEN – Research Report) on January 10 and set a price target of $207.00. The company’s shares …

businessinsider.com

$0.33
OFF

Repligen Shares Tumble On Disappointing 2024 Guidance

2 weeks from now

Feb 21, 2024 · BOSTON - Repligen (NASDAQ: RGEN) Corporation (NASDAQ: RGEN) reported its fourth-quarter earnings, matching analyst expectations with an adjusted EPS of $0.33. …

investing.com

20%
OFF

Repligen (RGEN) Insider Trading Activity 2025 - MarketBeat

2 weeks from now

2 days ago · What percentage of Repligen stock is owned by insiders? 1.20% of Repligen stock is owned by insiders. Learn more on RGEN's insider holdings. Which Repligen insiders have …

marketbeat.com

05%
OFF

Repligen Corp Stock Forecast, Predictions & Price Target

2 weeks from now

On average, Wall Street analysts predict. that Repligen's share price could reach $184.17 by Dec 17, 2025. The average Repligen stock price prediction forecasts a potential upside of 19.05% …

wallstreetzen.com

$176.50
OFF

Repligen Reaches Analyst Target Price - Nasdaq

2 weeks from now

Dec 15, 2023 · In recent trading, shares of Repligen Corp. (Symbol: RGEN) have crossed above the average analyst 12-month target price of $176.50, changing hands for $180.41/share. …

nasdaq.com

$154.86
OFF

Repligen Co. (NASDAQ:RGEN) Shares Bought By GAMMA …

2 weeks from now

4 days ago · Check Out Our Latest Stock Analysis on Repligen. Repligen Stock Performance. Repligen stock opened at $154.86 on Friday. The company has a debt-to-equity ratio of 0.26, …

etfdailynews.com

39%
OFF

Who Owns Repligen Corporation? Top Stakeholders Of RGEN …

2 weeks from now

Analyze quarterly positions in Repligen Corporation with up to 7 years of data, all consolidated into one spreadsheet ... T. Rowe Price Associates : 6.4M $951M 39% : Sep 2024 ... Raw data …

stockzoa.com

FAQs about Analysts Set Repligen Co. (NASDAQ:RGEN) Price Target at $185.20 Coupon?

What is the average 12 month price target for Repligen?

The average 12 month price target among analysts that have issued ratings on the stock in the last year is $185.20. A number of equities analysts have issued reports on the company. StockNews.com upgraded Repligen from a “sell” rating to a “hold” rating in a report on Friday, January 3rd. ...

Should you buy Repligen co (RGEN) stock?

Shares of Repligen Co. (NASDAQ:RGEN – Get Free Report) have earned an average recommendation of “Moderate Buy” from the thirteen research firms that are presently covering the stock, Marketbeat Ratings reports. Five analysts have rated the stock with a hold rating and eight have given a buy rating to the company. ...

Should you buy Repligen (Repligen)?

McNamara covers the Healthcare sector, focusing on stocks such as Hologic, Illumina, and QuidelOrtho. According to TipRanks, McNamara has an average return of -11.5% and a 33.55% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Repligen with a $198.17 average price target. ...

Is Repligen a good stock to buy?

Wolfe Research assumed coverage on shares of Repligen in a report on Thursday, November 14th. They set a “peer perform” rating for the company. Finally, Canaccord Genuity Group assumed coverage on Repligen in a research note on Tuesday, December 17th. They issued a “hold” rating and a $165.00 price target on the stock. ...

How much will Repligen (Repligen) earn per share?

On average, sell-side analysts expect that Repligen will post 1.54 earnings per share for the current year. (Get Free Report Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. ...

Who owns Repligen (RGEN)?

Finally, nVerses Capital LLC bought a new stake in shares of Repligen in the third quarter worth approximately $45,000. 97.64% of the stock is currently owned by hedge funds and other institutional investors. Shares of NASDAQ RGEN opened at $156.55 on Friday. Repligen has a 1 year low of $113.50 and a 1 year high of $211.13. ...